Skip to main content
. Author manuscript; available in PMC: 2024 May 21.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 May 1;29(12):2401–2410. doi: 10.1158/1055-9965.EPI-20-0237

Figure 3: EDRN Biomarker Triage System:

Figure 3:

EDRN has developed a triage system with a series of “go or no-go” decisions. Only when biomarkers have passed this rigorous process of verification, is a large clinical validation study undertaken.